Satsuma Pharmaceuticals, Inc. Proceeds from Stock Plans
Satsuma Pharmaceuticals, Inc. reported Proceeds from Stock Plans of $122.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2023-03-28
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2022-12-31 was $17.00K, a 71.67% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2022-09-30 was $0.00.
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2021-12-31 was $60.00K.
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2021-09-30 was $0.00.
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2022 was $122.00K, a 79.41% increase from fiscal 2021.
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2021 was $68.00K, a 49.25% decline from fiscal 2020.
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2020 was $134.00K, a 56.07% decline from fiscal 2019.
- Satsuma Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2019 was $305.00K.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2022-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $17.00K derived: sum of 2 quarters · filed 2023-03-28 | $122.00K 10-K · filed 2023-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $105.00K 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $105.00K 10-Q · filed 2022-08-09 | |||
| 2021-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $60.00K derived: sum of 2 quarters · filed 2023-03-28 | $68.00K 10-K · filed 2023-03-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $8.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $8.00K 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $134.00K 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $305.00K 10-K · filed 2021-03-25 |